Obexelimab, CAS 1690307-05-1

Product Description: Obexelimab (XmAb5871) is a humanized anti-CD19 antibody Fc-engineered for increased affinity to FcγRIIb. Obexelimab can be used in research of autoimmune[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Chu SY, et, al. Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor. Arthritis Rheumatol. 2014 May;66(5):1153-64.

CAS Number: 1690307-05-1

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: CD19

• Artikelnummer: MEXHY-P99761-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99761-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated